An intraductal papillary mucinous neoplasm (IPMN) is a benign or noncancerous cyst in the ducts of the pancreas. The cysts are sometimes precancerous, which means they may lead to pancreatic cancer.

The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and ...

Purinostat mesylate is under clinical development by Chengdu Zenitar Biomedical Technology and currently in Phase I for Unspecified B-Cell Lymphomas.

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas.

A patient with MPN urges others to ask questions about treatment options, which may also include inquiring about clinical ...

Criteria for NGS testing in MNs can reduce unnecessary tests, saving costs without affecting patient care quality. Six approval and six cancellation criteria guide appropriate NGS use, focusing on ...

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading ...

Arvinas focuses on protein degradation, with its lead candidate, ARV-471, in Phase 3 trials for breast cancer. Read why we ...

Advances in robotic-assisted surgery are redefining the approach to thyroid and parotid salivary gland conditions, offering solutions that prioritize precision, minimal invasiveness, and ...

Medical data points revolt, demand equality in healthcare access, and call for systemic change across all communities.

LBA-4: Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) SAN DIEGO, Dec. 10, 2024 ...

A new thesis from Karolinska Institutet shows the effectiveness of flexible parametric survival models in modeling multiple time-scales, providing a robust tool for complex time-to-event data ...